DK1363944T3 - Höjaffinitetsantagonister for ELR-CXC-kemokiner - Google Patents

Höjaffinitetsantagonister for ELR-CXC-kemokiner

Info

Publication number
DK1363944T3
DK1363944T3 DK02703428T DK02703428T DK1363944T3 DK 1363944 T3 DK1363944 T3 DK 1363944T3 DK 02703428 T DK02703428 T DK 02703428T DK 02703428 T DK02703428 T DK 02703428T DK 1363944 T3 DK1363944 T3 DK 1363944T3
Authority
DK
Denmark
Prior art keywords
elr
high affinity
cxc chemokines
affinity antagonists
antagonists
Prior art date
Application number
DK02703428T
Other languages
Danish (da)
English (en)
Inventor
John R Gordon
Fang Li
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of DK1363944T3 publication Critical patent/DK1363944T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Power Steering Mechanism (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
DK02703428T 2001-03-01 2002-03-01 Höjaffinitetsantagonister for ELR-CXC-kemokiner DK1363944T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27318101P 2001-03-01 2001-03-01

Publications (1)

Publication Number Publication Date
DK1363944T3 true DK1363944T3 (da) 2007-01-08

Family

ID=23042842

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02703428T DK1363944T3 (da) 2001-03-01 2002-03-01 Höjaffinitetsantagonister for ELR-CXC-kemokiner

Country Status (11)

Country Link
US (3) US7201895B2 (zh)
EP (1) EP1363944B1 (zh)
JP (1) JP2004534521A (zh)
AT (1) ATE339447T1 (zh)
AU (1) AU2002237136B2 (zh)
CA (1) CA2439452C (zh)
DE (1) DE60214676T2 (zh)
DK (1) DK1363944T3 (zh)
ES (1) ES2274957T3 (zh)
HK (1) HK1062689A1 (zh)
WO (1) WO2002070565A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE339447T1 (de) * 2001-03-01 2006-10-15 Univ Saskatchewan Hochaffine antagonisten der elr-cxc chemokine
CL2007001402A1 (es) 2006-05-16 2008-03-14 Univ Saskatchewan Technology T Peptidos agonistas y antagonistas de quimioquinas elr-cxc, capaces de ligarse a receptores cxcr1 y cxcr2; polinucleotidos que los codifican; y uso de los peptidos para tratar patologias mediadas por quimioquinas elr-cxc.
US8299019B2 (en) * 2008-02-12 2012-10-30 Gordon John R Uses of modified ELR-CXC chemokine G31P to treat cancer
WO2009100530A1 (en) * 2008-02-12 2009-08-20 University Of Saskatchewan Uses of modified elr-cxc chemokine g31p
KR101247641B1 (ko) * 2010-10-22 2013-03-29 성균관대학교산학협력단 Ｃｘｃｒ２에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물
ES2583093T3 (es) 2011-03-03 2016-09-19 Denovamed Inc. Compuestos antimicrobianos/adyuvantes
EP3848046A1 (en) 2013-06-18 2021-07-14 New York University Pharmaceutical compositions containing a mutated leukocidin e
US10075024B2 (en) 2015-05-22 2018-09-11 La-Z-Boy Incorporated Apparatus and method for wireless power transfer in furniture
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
US10980739B2 (en) 2016-12-14 2021-04-20 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN109022599A (zh) * 2018-10-08 2018-12-18 河南科技学院 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs
WO2020106704A2 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226649D1 (de) * 1991-12-04 1998-09-17 Biomedical Research Centre Ltd Analoge des menschlichen Interleukin-8.
WO1997000601A2 (en) * 1995-06-20 1997-01-09 Chiron Corporation Polypeptides with interleukin-8 receptor binding
ATE339447T1 (de) * 2001-03-01 2006-10-15 Univ Saskatchewan Hochaffine antagonisten der elr-cxc chemokine

Also Published As

Publication number Publication date
US20070021593A1 (en) 2007-01-25
DE60214676T2 (de) 2007-09-20
ES2274957T3 (es) 2007-06-01
WO2002070565A3 (en) 2002-12-19
ATE339447T1 (de) 2006-10-15
US7741434B2 (en) 2010-06-22
US20030077705A1 (en) 2003-04-24
CA2439452C (en) 2012-05-15
US7201895B2 (en) 2007-04-10
DE60214676D1 (de) 2006-10-26
WO2002070565A9 (en) 2002-10-31
AU2002237136B2 (en) 2007-11-01
US20090118469A1 (en) 2009-05-07
HK1062689A1 (en) 2004-11-19
WO2002070565A2 (en) 2002-09-12
CA2439452A1 (en) 2002-09-12
JP2004534521A (ja) 2004-11-18
EP1363944A2 (en) 2003-11-26
EP1363944B1 (en) 2006-09-13

Similar Documents

Publication Publication Date Title
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DK1363944T3 (da) Höjaffinitetsantagonister for ELR-CXC-kemokiner
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
AR030504A1 (es) Peptidos ciclicos selectivos
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
SG149693A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2003104410A3 (en) ENZYMES
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
BR0207933A (pt) Mutantes de interleucina-18, sua produção e uso
ATE419845T1 (de) Il-8-rezeptor-antagonisten
ATE348613T1 (de) Zolpidem hemitartrat solvat
WO2004087874A3 (en) Novel nucleic acids and polypeptides
EA200200933A1 (ru) Антагонисты рецептора il-8
ATE390482T1 (de) Interleukin-1 hy2. mittel und verfahren
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods
BRPI0507173A (pt) método para produzir polìmeros de polifenileno substituìdo
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses